Questcor Ups Quarterly Divy by 20%
- Posted by Danny
- on October 10th, 2013
Questcor ($QCOR), maker of Acthar Gel used to treat inflammatory and auto-immune disorders, hiked its quarterly dividend by $0.05 this morning from $0.25 to $0.30 per share. In the news release this morning CEO Don Bailey had this to say:
“Our second dividend increase this year reflects our strong financial performance to date, driven by increasing usage of Acthar among physicians to treat patients with serious, difficult to treat medical conditions. Our business is generating a growing amount of cash flow, as evidenced by Questcor’s $278 million in cash and investments at October 4, 2013. Our cash position includes $75 million in restricted cash, unchanged from the second quarter 2013. We remain committed to using our strong cash flow to invest in our business, including significant investments in R&D, while returning cash to shareholders. To date we have maintained a payout ratio—dividends paid per share divided by earnings per share—of approximately 20%.”
Sounds good to me.
The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.blog comments powered by Disqus
Daniel Miller and Jason Robinson are self taught investors based in Daphne, Alabama, and are the co-founders of the WallStreetBean. Neither one of them are professional investors - just two regular guys who want to share their investing ideas and thoughts with others. More